Skip to main content
SpringerLink
Log in

Device Clinical Trials

  • Chapter
  • First Online:
Clinical Dermatology Trials 101

Abstract

Conducting clinical trials can be a rewarding experience for the practicing physician, but they are also a lot of hard work. This chapter aims to provide a practical overview for those of you who may be interested in performing office-based clinical trials. Introductions will be made into the background of clinical trials, types of sites conducting trials, people conducting those trials, what may be needed at your location, regulatory information and a practical how-to guide to getting started doing your own studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Papp KA, Stober B, Augustin M, et al. PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents. J Drugs Dermatol. 2012;11(10):1210–7.

    CAS  PubMed  Google Scholar 

  2. Weinstock MA, Stampfer MJ, Lew RA, et al. Case-control study of melanoma and dietary vitamin D: implications for advocacy of sun protection and sunscreen use. J Invest Dermatol. 1992;98(5):809–11.

    Article  CAS  PubMed  Google Scholar 

  3. Tan J, Blume-Peytavi U, Ortonne JP, et al. An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Br J Dermatol. 2013;169(3):555–62.

    Article  CAS  PubMed  Google Scholar 

  4. Kimball AB, Guerin A, Latremouille-Viau D, et al. Coronary heart disease and stroke risk in patients with psoriasis: a retrospective analysis. Am J Med. 2010;123:350–7.

    Article  PubMed  Google Scholar 

  5. Leon AC, Davis LL, Kraemer HC. The role and interpretation of pilot studies in clinical research. J Psychiatr Res. 2011;45(5):626–9.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Jarratt M, Brundage T. Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study. J Drugs Dermatol. 2012;11(3):318–26.

    CAS  PubMed  Google Scholar 

  7. National Institutes of Health. http://www.nlm.nih.gov/services/ctphases.html. Accessed 31 Dec 2013.

  8. U.S. Food and Drug Administration (FDA). Establishment registration and device listing for manufacturers and initial importers of devices. Code of Federal Regulations, Title 21, Part 807 Subpart E, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=807&showFR=1&subpartNode=21:8.0.1.1.5.5. Accessed 31 Dec 2013.

  9. Dang JM, Krause D, Felten RP, Luke MK. Medical device regulation: what a practicing dermatologist should know. Dermatol Ther. 2009;22:241–5.

    Article  PubMed  Google Scholar 

  10. http://www.gpo.gov/fdsys/pkg/USCODE-2010-title21/pdf/USCODE-2010-title21-chap9-subchapV-partA-sec360e.pdf

  11. American Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Med Assoc. 2013;310(20):2191–4.

    Article  Google Scholar 

  12. http://phrp.nihtraining.com/users/login.php

  13. Strom BL, Kelly TO, Norman SA, et al. The Master of Science in Clinical Epidemiology Degree Program of the Perelman School of Medicine at the University of Pennsylvania: a model for clinical research training. Acad Med. 2012;87(1):74–80.

    Article  PubMed  Google Scholar 

  14. Teo AR. The Development of Clinical Research Training: past history and current trends in the United States. Acad Med. 2009;84:433–8.

    Article  PubMed  Google Scholar 

  15. U.S. Food and Drug Administration (FDA). Food and drugs: investigational new drug application. Code of Federal Regulations, Title 21, Part 312.60. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm. Accessed 24 Dec 2013.

  16. Fisher JA, Kalbaugh CA. United States Private-Sector Physicians and Pharmaceutical Contract Research: a qualitative study. PLoS Med. 2012;9(7):e1001271. doi:10.1371/journal.pmed.1001271. Accessed 24 Dec 2013.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Giffin RB, Woodcock J. Comparative effectiveness research: who will do the studies? Health Aff. 2010;29(11):2075–81.

    Article  Google Scholar 

  18. U.S. Department of Health and Human Services: Human Subjects Research (45 CFR 46). Washington, DC: U.S. Department of Health and Human Services; 2009.

    Google Scholar 

  19. Klitzman R. Institutional Review Board Community Members: who are they, what do they do, and whom do they represent? Acad Med. 2012;87:975–81.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Marsolo K. Approaches to Facilitate Institutional Review Board Approval of Multicenter Research Studies. Med Care. 2012;50:S77–81.

    Article  PubMed  Google Scholar 

  21. Pub L No. 111-148, 124 Stat 1025; 2010.

    Google Scholar 

  22. Sharma S. Working with pharmaceutical companies on investigator-initiated clinical trials. J Clin Res Best Pract. 2011;7(8):1–3.

    CAS  Google Scholar 

  23. Au SC, Goldminz AM, Kim N, et al. Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis. J Dermatolog Treat. 2013;24:179–97.

    Article  CAS  PubMed  Google Scholar 

  24. Weiss ET, Brauer JA, Anolik R, et al. 1927-nm fractional resurfacing of facial actinic keratoses: a promising new therapeutic option. J Am Acad Dermatol. 2013;68(1):98–102.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatology & Laser Center of Charleston and the Center for Clinical Research, 2180 Henry Tecklenburg Drive, Charleston, SC, 29414, USA

    Todd E. Schlesinger M.D.

Authors
  1. Todd E. Schlesinger M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Todd E. Schlesinger M.D. .

Editor information

Editors and Affiliations

  1. Dermatology, UNC School of Medicine, Chapel Hill, North Carolina, USA

    Adnan Nasir

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Schlesinger, T.E. (2015). Device Clinical Trials. In: Nasir, A. (eds) Clinical Dermatology Trials 101. Springer, Cham. https://doi.org/10.1007/978-3-319-09027-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-09027-6_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-09026-9

  • Online ISBN: 978-3-319-09027-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation